Akèy › Hypertension artérielle › Kansas
Etid klinik pou Hypertension artérielle nan Kansas
11 etid pou Hypertension artérielle ap chèche patisipan nan sit nan Kansas.
Vil nan Kansas
Tèks ofisyèl etid la (Anglè)
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- University of Kansas Medical Center, Kansas City
- Cardiovascular Research Institute of Kansas, Wichita
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06059638EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- AMR El Dorado, El Dorado
- Cotton O'Neil Diabetes & Endocrinology Center, Topeka
- Tekton Research - Wichita, Wichita
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Cotton O'Neil Clinical Research Center, Topeka
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07794579A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Hutchinson
- Research Site, Kansas City
- Research Site, Wichita
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06742723Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Hutchinson
- Clinical Trial Site, Kansas City
- Clinical Trial Site, Topeka
- ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07181109Global Paradise System US Post Approval Study
- Ascension via Christi St. Francis, Wichita
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT06297291A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Alliance for Multispecialty Research, Wichita
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Jul 30, 2026 · NCT07610278An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
- Alliance for Multispecialty Research, Wichita
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT07543120Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, El Dorado
- Vanda Investigative Site, Wichita
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Feb 27, 2026 · NCT07090161Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 1/2
Laj 35 a 65 · Tout sèks · Mizajou Jun 8, 2025 · NCT04715022Reversing Glucose and Lipid-mediated Vascular Dysfunction
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 18 a 79 · Tout sèks · Mizajou Jun 5, 2025 · NCT04832009Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.